{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:51:26Z","timestamp":1784357486791,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T00:00:00Z","timestamp":1498003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T00:00:00Z","timestamp":1498003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recently, sarcopenia has attracted attention as therapeutic target because it constitutes a risk factor for metabolic and cardiovascular diseases. We focused 5-aminolevulinic acid (ALA) which act as electron carriers in the mitochondrial electron transport system. The mice that received ALA for 8\u2009weeks gained muscle strength and endurance, and exhibited increased muscle mass and mitochondrial amount. Administration of ALA to sarcopenia mice aged 100\u2009weeks and chronic kidney disease (CKD) model mice also increased muscle mass and improved physical performance. Metabolome analysis revealed increased branched-chain amino acids (BCAAs) levels in the skeletal muscle of ALA-treated mice. Quantitative PCR analysis revealed decreased expression levels in branched-chain amino acid transaminases (BCATs) that degrade BCAAs and other muscle-degrading factors, and increased levels of mitochondria-activating factors. We also studied in cultured myocytes and obtained compatible results. ALA-treated mice tended to increase body weight, but reduced blood glucose level. These suggested that ALA treatment not only activated muscle mitochondria but also enhanced muscle mass through an increase in BCAAs contents, as to improve muscle strength, endurance and glucose tolerance in mice. In these ways, muscle mitochondrial activation with ALA is suggested to be useful for the treatment of sarcopenia and glucose intolerance.<\/jats:p>","DOI":"10.1038\/s41598-017-03917-0","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T20:44:48Z","timestamp":1497559488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Treatment of sarcopenia and glucose intolerance through mitochondrial activation by 5-aminolevulinic acid"],"prefix":"10.1038","volume":"7","author":[{"given":"Chikako","family":"Fujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Mitsuishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aika","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Uto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ryuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motowo","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Muraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,21]]},"reference":[{"key":"3917_CR1","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/S0140-6736(12)62131-X","volume":"381","author":"JA Salomon","year":"2013","unstructured":"Salomon, J. A. et al. Healthy life expectancy for 187 countries, 1990\u20132010: a systematic analysis for the Global Burden Disease Study 2010. Lancet. \n                           381, 2144\u20132162 (2013).","journal-title":"Lancet."},{"key":"3917_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/sj.ejcn.1602066","volume":"59","author":"C Krems","year":"2005","unstructured":"Krems, C., Luhrmann, P. M., Strassburg, A., Hartmann, B. & Neuhauser-Berthold, M. Lower resting metabolic rate in the elderly may not be entirely due to changes in body composition. Eur J Clin Nutr. \n                           59, 255\u2013262 (2005).","journal-title":"Eur J Clin Nutr."},{"key":"3917_CR3","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1001\/jama.295.17.2018","volume":"295","author":"AB Newman","year":"2006","unstructured":"Newman, A. B. et al. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA. \n                           295, 2018\u20132026 (2006).","journal-title":"JAMA."},{"key":"3917_CR4","doi-asserted-by":"publisher","first-page":"b3292","DOI":"10.1136\/bmj.b3292","volume":"339","author":"BL Heitmann","year":"2009","unstructured":"Heitmann, B. L. & Frederiksen, P. Thigh circumference and risk of heart disease and premature death: prospective cohort study. BMJ. \n                           339, b3292 (2009).","journal-title":"BMJ."},{"key":"3917_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0022-510X(88)90132-3","volume":"84","author":"J Lexell","year":"1988","unstructured":"Lexell, J., Taylor, C. C. & Sjostrom, M. What is the cause of the ageing atrophy? Total number, size and proportion of different fibre types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci. \n                           84, 275\u2013294 (1988).","journal-title":"J Neurol Sci."},{"key":"3917_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.clnu.2014.08.007","volume":"34","author":"S Stelten","year":"2015","unstructured":"Stelten, S. et al. Protein-enriched \u2018regular products\u2019 and their effect on protein intake in acute hospitalized older adults; a randomized controlled trial. Clin Nutr. \n                           34, 409\u2013414 (2015).","journal-title":"Clin Nutr."},{"key":"3917_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/gerona\/59.1.M48","volume":"59","author":"NK Latham","year":"2004","unstructured":"Latham, N. K., Bennett, D. A., Stretton, C. M. & Anderson, C. S. Systematic review of progressive resistance strength training in older adults. J Gerontol. \n                           59, 48\u201361 (2004).","journal-title":"J Gerontol."},{"key":"3917_CR8","first-page":"E601","volume":"282","author":"AA Ferrando","year":"2002","unstructured":"Ferrando, A. A. et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol End. \n                           282, E601\u2013E607 (2002).","journal-title":"Am J Physiol End."},{"key":"3917_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.maturitas.2011.11.012","volume":"71","author":"V Malafarina","year":"2012","unstructured":"Malafarina, V., Uriz-Otano, F., Iniesta, R. & Gil-Guerrero, L. Sarcopenia in the elderly: diagnosis, physiopathology and treatment. Maturitas. \n                           71, 109\u2013114 (2012).","journal-title":"Maturitas."},{"key":"3917_CR10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1046\/j.1532-5415.2003.51405.x","volume":"51","author":"NK Latham","year":"2003","unstructured":"Latham, N. K., Anderson, C. S. & Reid, I. R. Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: a systematic review. J Am Geriatr Soc. \n                           51, 1219\u20131226 (2003).","journal-title":"J Am Geriatr Soc."},{"key":"3917_CR11","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.2174\/1381612821666150130122032","volume":"21","author":"AM Martone","year":"2015","unstructured":"Martone, A. M. et al. Treating sarcopenia in older and oldest old. Curr Pharm Des. \n                           21, 1715\u201322 (2015).","journal-title":"Curr Pharm Des."},{"key":"3917_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0025-6196(11)60964-6","volume":"82","author":"RM Haddad","year":"2007","unstructured":"Haddad, R. M. et al. Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials. Mayo Clin Proc. \n                           82, 29\u201339 (2007).","journal-title":"Mayo Clin Proc."},{"key":"3917_CR13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.1082889","volume":"300","author":"KF Petersen","year":"2003","unstructured":"Petersen, K. F. et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. \n                           300, 1140\u20131142 (2003).","journal-title":"Science."},{"key":"3917_CR14","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1073\/pnas.0501559102","volume":"102","author":"KR Short","year":"2005","unstructured":"Short, K. R. et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci USA. \n                           102, 5618\u20135623 (2005).","journal-title":"Proc Natl Acad Sci USA."},{"key":"3917_CR15","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMoa031314","volume":"350","author":"KF Petersen","year":"2004","unstructured":"Petersen, K. F., Dufour, S., Befroy, D., Garcia, R. & Shulman, G. I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. \n                           350, 664\u201371 (2004).","journal-title":"N Engl J Med."},{"key":"3917_CR16","doi-asserted-by":"publisher","first-page":"e11468","DOI":"10.1371\/journal.pone.0011468","volume":"5","author":"A Hiona","year":"2010","unstructured":"Hiona, A. et al. Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice. PLoS One. \n                           5, e11468 (2010).","journal-title":"PLoS One."},{"key":"3917_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1152\/japplphysiol.01362.2011","volume":"113","author":"A Muraki","year":"2012","unstructured":"Muraki, A. et al. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance. J Appl Physiol. \n                           113, 479\u201386 (2012).","journal-title":"J Appl Physiol."},{"key":"3917_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1756-0500-4-66","volume":"4","author":"S Ogura","year":"2011","unstructured":"Ogura, S. et al. The effect of 5-aminolevulinic acid on cytochrome c oxidase activity in mouse liver. BMC Res Notes. \n                           4, 66 (2011).","journal-title":"BMC Res Notes."},{"key":"3917_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11738-008-0198-7","volume":"31","author":"SA Memon","year":"2009","unstructured":"Memon, S. A., Hou, X., Wang, L. & Li, Y. Promotive effect of 5-aminolevulinic acid on chlorophyll, antioxidative enzymes and photosynthesis of Pakchoi (Brassica campestris ssp.chinensis var. communis Tsen et Lee). Acta Physiol Plant. \n                           31, 51\u201357 (2009).","journal-title":"Acta Physiol Plant."},{"key":"3917_CR20","first-page":"233","volume":"1","author":"OA Meyer","year":"1979","unstructured":"Meyer, O. A., Tilson, H. A., Byrd, W. C. & Riley, M. T. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol. \n                           1, 233\u2013236 (1979).","journal-title":"Neurobehav Toxicol."},{"key":"3917_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cmet.2006.12.003","volume":"5","author":"Z Arany","year":"2007","unstructured":"Arany, Z. et al. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. \n                           5, 35\u201346 (2007).","journal-title":"Cell Metab."},{"key":"3917_CR22","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1359\/jbmr.1999.14.7.1167","volume":"7","author":"T Hildebrand","year":"1999","unstructured":"Hildebrand, T., Laib, A., M\u00fcller, R., Dequeker, J. & R\u00fcegsegger, P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res. \n                           7, 1167\u20131174 (1999).","journal-title":"J Bone Miner Res."},{"key":"3917_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/bonekey.2014.59","volume":"3","author":"GM Campbell","year":"2014","unstructured":"Campbell, G. M. & Sophocleous, A. Quantitative analysis of bone and soft tissue by micro-computed tomography: applications to ex vivo and in vivo studies. Bonekey Rep. \n                           3, 564 (2014).","journal-title":"Bonekey Rep."},{"key":"3917_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrm2672","volume":"10","author":"XM Ma","year":"2009","unstructured":"Ma, X. M. & Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. \n                           10, 307\u2013318 (2009).","journal-title":"Nat Rev Mol Cell Biol."},{"key":"3917_CR25","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/ki.2013.473","volume":"85","author":"M Tamaki","year":"2014","unstructured":"Tamaki, M. et al. Chronic kidney disease reduces muscle mitochondria and exercise endurance and its exacerbation by dietary protein through inactivation of pyruvate dehydrogenase. Kidney Int. \n                           85, 1330\u20131339 (2014).","journal-title":"Kidney Int."},{"key":"3917_CR26","doi-asserted-by":"publisher","first-page":"e80850","DOI":"10.1371\/journal.pone.0080850","volume":"8","author":"Y Terada","year":"2013","unstructured":"Terada, Y. et al. 5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo. PLoS One. \n                           8, e80850 (2013).","journal-title":"PLoS One."},{"key":"3917_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1152\/japplphysiol.00582.2015","volume":"120","author":"S Masuki","year":"2016","unstructured":"Masuki, S. et al. Impact of 5-aminolevulinic acid with iron supplementation on exercise efficiency and home-based walking training achievement in older women. J Appl Physiol. \n                           120, 87\u201396 (2016).","journal-title":"J Appl Physiol."},{"key":"3917_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.intimp.2014.02.003","volume":"19","author":"N Yoshiaki","year":"2014","unstructured":"Yoshiaki, N. et al. 5-Aminolevulinic acid combined with ferrous iron enhances the expression of heme oxygenase-1. Int Immunopharmacol. \n                           19, 300\u2013307 (2014).","journal-title":"Int Immunopharmacol."},{"key":"3917_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.mam.2006.08.010","volume":"27","author":"M Kadowaki","year":"2006","unstructured":"Kadowaki, M., Karim, M. R., Carpi, A. & Miotto, G. Nutrient control of macroautophagy in mammalian cells. Mol Aspects Med. \n                           27, 426\u2013443 (2006).","journal-title":"Mol Aspects Med."},{"key":"3917_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.nut.2005.12.008","volume":"22","author":"J Donato","year":"2006","unstructured":"Donato, J., Pedrosa, R. G., Cruzat, V. F., de Oliveira Pires, I. S. & Tirapegui, J. Effects of leucine supplementation on the body composition and protein status of rat submitted to food restriction. Nutrition. \n                           22, 520\u2013527 (2006).","journal-title":"Nutrition."},{"key":"3917_CR31","doi-asserted-by":"publisher","first-page":"69E","DOI":"10.1016\/j.amjcard.2008.03.004","volume":"101","author":"SB Solerte","year":"2008","unstructured":"Solerte, S. B. et al. Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia. Am J Cardiol. \n                           101, 69E\u201377E (2008).","journal-title":"Am J Cardiol."},{"key":"3917_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cmet.2007.08.003","volume":"6","author":"P She","year":"2007","unstructured":"She, P. et al. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab. \n                           6, 181\u2013194 (2007).","journal-title":"Cell Metab."},{"key":"3917_CR33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/ajcn\/49.3.559","volume":"49","author":"D Rudman","year":"1989","unstructured":"Rudman, D., Mattson, D. E., Feller, A. G., Cotter, R. & Johnson, R. C. Fasting plasma amino acids in elderly men. Am J Clin Nutr. \n                           49, 559\u2013566 (1989).","journal-title":"Am J Clin Nutr."},{"key":"3917_CR34","doi-asserted-by":"publisher","first-page":"582","DOI":"10.2337\/dc15-2284","volume":"4","author":"CC Lee","year":"2016","unstructured":"Lee, C. C. et al. Branched-chain amino acids and insulin metabolism: the insulin resistance atherosclerosis study (IRAS). Diabetes Care. \n                           4, 582\u2013588 (2016).","journal-title":"Diabetes Care."},{"key":"3917_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/jdi.12345","volume":"4","author":"X Chen","year":"2015","unstructured":"Chen, X. & Young, W. Branched-chain amino acids and the association with type II diabetes. J Diabetes Investig. \n                           4, 369\u2013370 (2015).","journal-title":"J Diabetes Investig."},{"key":"3917_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"4","author":"CB Newgard","year":"2009","unstructured":"Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. \n                           4, 311\u2013326 (2009).","journal-title":"Cell Metab."},{"key":"3917_CR37","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","volume":"12","author":"CJ Lynch","year":"2014","unstructured":"Lynch, C. J. & Adams, S. H. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol. \n                           12, 723\u201336 (2014).","journal-title":"Nat Rev Endocrinol."},{"key":"3917_CR38","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.nutres.2014.04.013","volume":"34","author":"T Sato","year":"2014","unstructured":"Sato, T. et al. Type 2 diabetic conditions in Otsuka Long-Evans Tokushima Fatty rats are ameliorated by 5-aminolevulinic acid. Nutr Res. \n                           34, 544\u2013551 (2014).","journal-title":"Nutr Res."},{"key":"3917_CR39","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1752-8062.2012.00421.x","volume":"5","author":"BL Rodriguez","year":"2012","unstructured":"Rodriguez, B. L. et al. Use of the dietary supplement 5-aminiolevulinic acid (5-ALA) and its relationship with glucose levels and hemoglobin A1C among individuals with prediabetes. Clin Transl Sci. \n                           5, 314\u2013320 (2012).","journal-title":"Clin Transl Sci."},{"key":"3917_CR40","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.nut.2013.02.008","volume":"29","author":"F Higashikawa","year":"2013","unstructured":"Higashikawa, F., Noda, M., Awaya, T., Tanaka, T. & Sugiyama, M. 5-aminolevulinic acid, a precursor of heme, reduces both fasting and postprandial glucose levels in mildly hyperglycemic subjects. Nutrition. \n                           29, 1030\u20131036 (2013).","journal-title":"Nutrition."},{"key":"3917_CR41","doi-asserted-by":"publisher","first-page":"8294805","DOI":"10.1155\/2016\/8294805","volume":"2016","author":"F Al-Saber","year":"2016","unstructured":"Al-Saber, F. et al. The Safety and Tolerability of 5-Aminolevulinic Acid Phosphate with Sodium Ferrous Citrate in Patients with Type 2 Diabetes Mellitus in Bahrain. J Diabetes Res. \n                           2016, 8294805 (2016).","journal-title":"J Diabetes Res."},{"key":"3917_CR42","doi-asserted-by":"publisher","first-page":"E49","DOI":"10.1152\/ajpendo.00317.2009","volume":"298","author":"VB Ritov","year":"2010","unstructured":"Ritov, V. B. et al. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Physiol Endocrinol Metab. \n                           298, E49\u2013E58 (2010).","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"3917_CR43","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1210\/jc.2011-0435","volume":"96","author":"P Srikanthan","year":"2011","unstructured":"Srikanthan, P. & Karlamangla, A. S. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. \n                           96, 2898\u20132903 (2011).","journal-title":"J Clin Endocrinol Metab."},{"key":"3917_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.regpep.2011.09.001","volume":"173","author":"PJ Verhulst","year":"2012","unstructured":"Verhulst, P. J., Janssen, S., Tack, J. & Depoortere, I. Role of the AMP-activated protein kinase (AMPK) signaling pathway in the orexigenic effects of endogenous ghrelin. Regul Pept. \n                           173, 27\u201335 (2012).","journal-title":"Regul Pept."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03917-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03917-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03917-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:42:22Z","timestamp":1671774142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03917-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["3917"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-03917-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,21]]},"assertion":[{"value":"9 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research grant numbers JP26460920 to K.M. Research grants were provided from SBI Pharma to K.M. and H.I.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4013"}}